世界の分岐部病変治療市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV11041)
◆英語タイトル:Global Bifurcation Lesions Treatment Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV11041
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:97
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは分岐部病変治療の世界市場について調査・分析した資料です。種類別(Tステント、キュロット、クラッシュ、Vステント、Yステント、ジェイルドバルーン)の市場規模、用途別(冠状血管、末梢血管)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別分岐部病変治療の競争状況、市場シェア
・世界の分岐部病変治療市場:種類別市場規模 2015年-2020年(Tステント、キュロット、クラッシュ、Vステント、Yステント、ジェイルドバルーン)
・世界の分岐部病変治療市場:種類別市場規模予測 2021年-2026年(Tステント、キュロット、クラッシュ、Vステント、Yステント、ジェイルドバルーン)
・世界の分岐部病変治療市場:用途別市場規模 2015年-2020年(冠状血管、末梢血管)
・世界の分岐部病変治療市場:用途別市場規模予測 2021年-2026年(冠状血管、末梢血管)
・北米の分岐部病変治療市場分析:米国、カナダ
・ヨーロッパの分岐部病変治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの分岐部病変治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の分岐部病変治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの分岐部病変治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Medtronic、Boston Scientific Corporation、Johnson& Johnson Services, Inc、Abbott、C. R. Bard, Inc.、Spectranetics、Terumo Medical Corporation、Cardinal Health
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Bifurcation Lesions Treatment Market
The global Bifurcation Lesions Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Bifurcation Lesions Treatment Scope and Market Size
Bifurcation Lesions Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bifurcation Lesions Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Medtronic
Boston Scientific Corporation
Johnson& Johnson Services, Inc
Abbott
C. R. Bard, Inc.
Spectranetics
Terumo Medical Corporation
Cardinal Health

Market segment by Type, the product can be split into
T Stent
Culotte
Crush
V Stent
Y Stent
Jailed Balloon
Market segment by Application, split into
Coronary Vascular
Peripheral Vascular

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bifurcation Lesions Treatment Revenue
1.4 Market by Type
1.4.1 Global Bifurcation Lesions Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 T Stent
1.4.3 Culotte
1.4.4 Crush
1.4.5 V Stent
1.4.6 Y Stent
1.4.7 Jailed Balloon
1.5 Market by Application
1.5.1 Global Bifurcation Lesions Treatment Market Share by Application: 2020 VS 2026
1.5.2 Coronary Vascular
1.5.3 Peripheral Vascular
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Bifurcation Lesions Treatment Market Perspective (2015-2026)
2.2 Global Bifurcation Lesions Treatment Growth Trends by Regions
2.2.1 Bifurcation Lesions Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bifurcation Lesions Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Bifurcation Lesions Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Bifurcation Lesions Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Bifurcation Lesions Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Bifurcation Lesions Treatment Players by Market Size
3.1.1 Global Top Bifurcation Lesions Treatment Players by Revenue (2015-2020)
3.1.2 Global Bifurcation Lesions Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Bifurcation Lesions Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bifurcation Lesions Treatment Market Concentration Ratio
3.2.1 Global Bifurcation Lesions Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bifurcation Lesions Treatment Revenue in 2019
3.3 Bifurcation Lesions Treatment Key Players Head office and Area Served
3.4 Key Players Bifurcation Lesions Treatment Product Solution and Service
3.5 Date of Enter into Bifurcation Lesions Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Bifurcation Lesions Treatment Historic Market Size by Type (2015-2020)
4.2 Global Bifurcation Lesions Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Bifurcation Lesions Treatment Market Size by Application (2015-2020)
5.2 Global Bifurcation Lesions Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Bifurcation Lesions Treatment Market Size (2015-2020)
6.2 Bifurcation Lesions Treatment Key Players in North America (2019-2020)
6.3 North America Bifurcation Lesions Treatment Market Size by Type (2015-2020)
6.4 North America Bifurcation Lesions Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Bifurcation Lesions Treatment Market Size (2015-2020)
7.2 Bifurcation Lesions Treatment Key Players in Europe (2019-2020)
7.3 Europe Bifurcation Lesions Treatment Market Size by Type (2015-2020)
7.4 Europe Bifurcation Lesions Treatment Market Size by Application (2015-2020)

8 China
8.1 China Bifurcation Lesions Treatment Market Size (2015-2020)
8.2 Bifurcation Lesions Treatment Key Players in China (2019-2020)
8.3 China Bifurcation Lesions Treatment Market Size by Type (2015-2020)
8.4 China Bifurcation Lesions Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Bifurcation Lesions Treatment Market Size (2015-2020)
9.2 Bifurcation Lesions Treatment Key Players in Japan (2019-2020)
9.3 Japan Bifurcation Lesions Treatment Market Size by Type (2015-2020)
9.4 Japan Bifurcation Lesions Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Bifurcation Lesions Treatment Market Size (2015-2020)
10.2 Bifurcation Lesions Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bifurcation Lesions Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Bifurcation Lesions Treatment Market Size by Application (2015-2020)

11 India
11.1 India Bifurcation Lesions Treatment Market Size (2015-2020)
11.2 Bifurcation Lesions Treatment Key Players in India (2019-2020)
11.3 India Bifurcation Lesions Treatment Market Size by Type (2015-2020)
11.4 India Bifurcation Lesions Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Bifurcation Lesions Treatment Market Size (2015-2020)
12.2 Bifurcation Lesions Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Bifurcation Lesions Treatment Market Size by Type (2015-2020)
12.4 Central & South America Bifurcation Lesions Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Medtronic
13.1.1 Medtronic Company Details
13.1.2 Medtronic Business Overview
13.1.3 Medtronic Bifurcation Lesions Treatment Introduction
13.1.4 Medtronic Revenue in Bifurcation Lesions Treatment Business (2015-2020))
13.1.5 Medtronic Recent Development
13.2 Boston Scientific Corporation
13.2.1 Boston Scientific Corporation Company Details
13.2.2 Boston Scientific Corporation Business Overview
13.2.3 Boston Scientific Corporation Bifurcation Lesions Treatment Introduction
13.2.4 Boston Scientific Corporation Revenue in Bifurcation Lesions Treatment Business (2015-2020)
13.2.5 Boston Scientific Corporation Recent Development
13.3 Johnson& Johnson Services, Inc
13.3.1 Johnson& Johnson Services, Inc Company Details
13.3.2 Johnson& Johnson Services, Inc Business Overview
13.3.3 Johnson& Johnson Services, Inc Bifurcation Lesions Treatment Introduction
13.3.4 Johnson& Johnson Services, Inc Revenue in Bifurcation Lesions Treatment Business (2015-2020)
13.3.5 Johnson& Johnson Services, Inc Recent Development
13.4 Abbott
13.4.1 Abbott Company Details
13.4.2 Abbott Business Overview
13.4.3 Abbott Bifurcation Lesions Treatment Introduction
13.4.4 Abbott Revenue in Bifurcation Lesions Treatment Business (2015-2020)
13.4.5 Abbott Recent Development
13.5 C. R. Bard, Inc.
13.5.1 C. R. Bard, Inc. Company Details
13.5.2 C. R. Bard, Inc. Business Overview
13.5.3 C. R. Bard, Inc. Bifurcation Lesions Treatment Introduction
13.5.4 C. R. Bard, Inc. Revenue in Bifurcation Lesions Treatment Business (2015-2020)
13.5.5 C. R. Bard, Inc. Recent Development
13.6 Spectranetics
13.6.1 Spectranetics Company Details
13.6.2 Spectranetics Business Overview
13.6.3 Spectranetics Bifurcation Lesions Treatment Introduction
13.6.4 Spectranetics Revenue in Bifurcation Lesions Treatment Business (2015-2020)
13.6.5 Spectranetics Recent Development
13.7 Terumo Medical Corporation
13.7.1 Terumo Medical Corporation Company Details
13.7.2 Terumo Medical Corporation Business Overview
13.7.3 Terumo Medical Corporation Bifurcation Lesions Treatment Introduction
13.7.4 Terumo Medical Corporation Revenue in Bifurcation Lesions Treatment Business (2015-2020)
13.7.5 Terumo Medical Corporation Recent Development
13.8 Cardinal Health
13.8.1 Cardinal Health Company Details
13.8.2 Cardinal Health Business Overview
13.8.3 Cardinal Health Bifurcation Lesions Treatment Introduction
13.8.4 Cardinal Health Revenue in Bifurcation Lesions Treatment Business (2015-2020)
13.8.5 Cardinal Health Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Medtronic、Boston Scientific Corporation、Johnson& Johnson Services, Inc、Abbott、C. R. Bard, Inc.、Spectranetics、Terumo Medical Corporation、Cardinal Health

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の分岐部病変治療市場2026:インサイト・予測(Global Bifurcation Lesions Treatment Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。